ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
There can be a feeling of winding down on Wednesdays at American Chemical Society national meetings. The expo is closed, and many attendees have begun to travel home after three days jam-packed with chemistry.
But for devotees of drug discovery, things were just gearing up in San Francisco on Wednesday for the day-long First-Time Disclosures symposium. Hosted by the Division of Medicinal Chemistry, this perennially popular and packed two-part symposium (part I, part II) features pharmaceutical and biotech company chemists unveiling the structures of their clinical candidates for the first time.
Eleven companies revealed a whopping 16 candidates at this meeting’s symposium—twice as many as were unveiled last spring in San Diego. Take a look at the structures as C&EN's Bethany Halford did her best to battle hand cramps and sketch and report them in real time.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X